Total revenues increased 71% year-over-year to $24 million.
Loss and loss adjustment expenses swung to a $3 million benefit.
Non-compliance with single-risk limits may restrict new business transactions.
Accumulated unpaid interest on surplus notes has reached $1.7 billion.
The Q1 2026 filing reveals a company in a state of managed decline, where the ability to survive depends on the speed of legacy wind-downs versus the rate of new credit impairments. On one hand, the U.S. public finance segment is showing genuine operational resilience and profitability. On the other, the corporate entity is burdened by a negative book value and a complex web of regulatory restrictions that limit its ability to return capital to shareholders. Investors are essentially betting on a race between the maturation of legacy liabilities and the potential for a catastrophic credit event in the remaining insured portfolios. While the shift toward an asset-light model is a positive strategic direction, the lack of regulatory approval for surplus note payments and the ongoing volatility of the PREPA litigation suggest that the path to a full recovery remains fraught with systemic risk.